Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella), Single Dose and Multidose Presentations in Children 12 to 23 Months of Age.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2016
At a glance
- Drugs Measles mumps and rubella virus vaccine (Primary)
- Indications Measles; Mumps; Rubella
- Focus Pharmacodynamics
- 07 Jul 2016 Status changed from recruiting to completed.
- 05 Feb 2013 New trial record